PLEDPHARMA
PledPharma AB, a pharmaceutical company, develops various pharmaceutical products to treat life threatening diseases. It primarily develops PledOx that is in Phase IIb clinical trials to reduce severe side effects of chemotherapy in patients with colorectal cancer. The company’s project pipeline includes Aladote (PP-100), which is in the Phase II clinical trials for the treatment of acute liver failure in conjunction with acetaminophen poisoning; and PP-099 that has completed Phase IIa clinical trials for the treatment of acute myocardial infarction.
PLEDPHARMA
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2006-01-01
Address:
Stockholm, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.pledpharma.se
Total Employee:
1+
Status:
Active
Contact:
(468)679-7210
Technology used in webpage:
SPF DNSSEC Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS LiteSpeed CPanel New Relic Loopia DNS
Similar Organizations
4P-Pharma
4P-Pharma is a clinical-stage company that develops regenerating active drugs and therapies to cure untreated serious diseases.
AM Pharma
AM-Pharma is a biopharmaceutical company focused on the development of therapeutics to treat inflammatory and infectious diseases.
BIOVIIIx
BIOVIIIx is a biotechnology and pharmaceutical company that develops medicine in the field of rare diseases.
Etna Biotech
Etna Biotech is a company that researches and develops vaccines and immunotherapeutics for infectious diseases.
Ideogen Group
IDEOGEN Group is a family owned Swiss pharmaceutical group, providing global access to specialty medicines for unmet medical needs.
Lofarma S.p.A.
Lofarma is the leading pharmaceutical company in the diagnosis and treatment of allergic respiratory diseases.
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Pharmathen
Pharmathen is a private pharmaceutical company developing generic drugs.
Zymedi
Zymedi is a pharmaceutical company that develops drugs for life-threatening diseases.
Current Advisors List
Current Employees Featured
Stock Details
Official Site Inspections
http://www.pledpharma.se
- Host name: 104.21.73.51
- IP address: 104.21.73.51
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "PledPharma"
PledPharma changes its name to Egetis ... - Egetis Therapeutics
Stockholm, Sweden, December 17, 2020. PledPharma AB (publ) (ticker: PLED) today announced that the company has formally changed its name to Egetis Therapeutics AB (publ) (ticker: …See details»
PledPharma - Crunchbase Company Profile & Funding
Organization. PledPharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. PledPharma is a Swedish pharmaceutical …See details»
PledPharma - egetis.com
Jacques was PledPharma’sCEO prior to Westerholm joining PledPharma in 2011. More than 30 years of experience within the life science space with positions at Q-Med AB and AstraZeneca …See details»
PledPharma strengthens its organization - Egetis Therapeutics
Sep 20, 2011 PledPharma AB Company Announcement PledPharma strengthens its organization Stockholm, 2011-09-20 08:30 CEST (GLOBE NEWSWIRE) -- PledPharma …See details»
PledPharma : becomes Egetis Therapeutics with a focus on the ...
Dec 18, 2020 Stockholm - PledPharma AB (publ) (ticker: PLED) announced today that the company has formally changed its name to Egetis Therapeutics AB (publ) (ticker: EGTX).. The …See details»
PledPharma AB - LinkedIn
PledPharma AB | 475 followers on LinkedIn. PledPharma develops new drugs that protect the body against oxidative stress – a potentially debilitating and sometimes life-threatening condition that ...See details»
PledPharma strengthens its organization - GlobeNewswire
Sep 20, 2011 PledPharma strengthens its organization. September 20, 2011 02:30 ET ... Stockholm, 2011-09-20 08:30 CEST (GLOBE NEWSWIRE) -- PledPharma ... please visit …See details»
Company PledPharma AB (publ) Nasdaq Stockholm
PledPharma AB (publ): Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Nasdaq Stockholm ...See details»
PledPharma AB Company Profile | StatInvestor
PledPharma AB operates as a pharmaceutical company, which engages in the development of new drugs that protect the body against oxidative stress, a potentially disabling and sometimes …See details»
Egetis Therapeutics - Craft
Feb 17, 2021 Egetis Therapeutics (formerly known as PledPharma) is a pharmaceutical drug development company. It develops drugs aimed at protecting the body against oxidative …See details»
PledPharma förstärker sin organisation - GlobeNewswire
Stockholm, 2011-09-20 08:30 CEST (GLOBE NEWSWIRE) -- PledPharma (STO:PLED) meddelar idag att man anställt Marie Bengtson som ansvarig för kliniska projekt, ... se www.pledpharma.se.See details»
PledPharma AB: Contact Details and Business Profile - RocketReach
PledPharma AB is a Biotechnology, Pharmaceutical Manufacturing, and Drug Manufacturing & Research company located in Stockholm, Stockholm County with $5.00 Million in revenue and …See details»
MFN.se > PledPharma > PledPharma ingår avtal om att förvärva …
Oct 5, 2020 Nicklas Westerholm, Verkställande direktör Tel. 073 354 20 62 [email protected] Peder Walberg, CEO Rare Thyroid Therapeutics Tel. +46 …See details»
MFN.se > PledPharma > PledPharma changes its name to Egetis ...
Stockholm, Sweden, December 17, 2020. PledPharma AB (publ) (ticker: PLED) today announced that the company has formally changed its name to Egetis Therapeutics AB (publ) (ticker: …See details»
PledPharma strengthens its organization - GlobeNewswire
Sep 20, 2011 PledPharma strengthens its organization. September 20, 2011 02:30 ET | Source: PledPharma AB Stockholm, 2011-09-20 08 ... For more information, please visit …See details»
PledPharma’s Japanese patient worth millions
This is a large area and, since we are working in the late phase of clinical drug research, it is natural that much of the expertise is in Gothenburg,” says Nicklas Westerholm, CEO at …See details»
PledPharma to acquire Rare Thyroid Therapeutics, creating a new …
Oct 5, 2020 • Clear path to launch in EU and US through niche commercial organization within approx 3 years ... PledPharma AB (publ) (STO: PLED) (“PledPharma” or the “Company”) has …See details»
PledPharma AB Company Insights, Tech Stack, and Competitors
PledPharma develops new drugs that protect the body against oxidative stress – a potentially debilitating and sometimes life-threatening condition that can be caused by chemotherapy …See details»
Egetis Therapeutics AB (publ) (EGTX) - Investing.com Svenska
PledPharma AB (publ) är ett Sverigebaserat biofarmaceutiskt företag som ägnar sig åt utveckling av behandlingar som ökar effektiviteten av terapier för allvarliga livshotande sjukdomar. …See details»
The first patient included in PledPharma’s global Phase III
STOCKHOLM, November 8, 2018 — PledPharma AB (publ), a Swedish pharmaceutical developer, today announced that the first patient has been enrolled in the company’s global …See details»